Skip to main content
. Author manuscript; available in PMC: 2012 Nov 28.
Published in final edited form as: Cancer Lett. 2011 Jul 1;310(2):148–159. doi: 10.1016/j.canlet.2011.06.029

Fig. 1. Combined cytotoxic effect of sTRAIL and proteasome inhibitors in human glioma cell lines.

Fig. 1

U87 and HOG glioma cell lines were treated with hrTRAIL for 24 hours followed by measurement of cytotoxicity (upper panel). The combined cytotoxic effects of epoxomicin and bortezomib and sTRAIL are presented in middle and lower panel, respectively. Data are shown as mean±SD, * p<0.05.